Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001442002-13-000001
Filing Date
2013-12-13
Accepted
2013-12-13 21:28:55
Documents
1
Period of Report
2013-11-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5299
  Complete submission text file 0001442002-13-000001.txt   6903
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Issuer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227-15 NORTH CONDUIT AVE LAURELTON NY 11413-3134
Business Address 227-15 NORTH CONDUIT AVE LAURELTON NY 11413-3134 718-276-8600
EPIC PHARMA LLC (Reporting) CIK: 0001442002 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-15697 | Film No.: 131277547